Disorder "Alzheimer's Disease"
Found 124 records
Disorder information
Disorder name:
Alzheimer's Disease
Disoder ID:
Synonyms:
Alzheimer disease, Alzheimers dementia
Definition:
A degenerative disease of the brain characterized by the insidious onset of dementia. Impairment of memory, judgment, attention span, and problem solving skills are followed by severe apraxia and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
Modifier statisitcs
Record:
124
Gene:
64
Variant:
115
Reference:
37
Effect type:
Expressivity(97)
,Penetrance(27)
Modifier effect:
Altered onset time(62)
,Altered incidence(27)
,Risk factor(25)
,Risk factor and Altered onset time(3)
,Altered gene activity(2)
,Altered cognitive performances(1)
,Altered intraocular pressure(1)
,Altered optic nerve damage(1)
,Altered severity(1)
,Altered severity and onset time(1)
| Modifier gene | Variant | Effect type | Modifier effect | Evidence | Effect | PubMed ID |
|---|---|---|---|---|---|---|
| GREM2 | GREM2:n.48+52610C>T | Expressivity | Altered onset time | P=1.69×10(-13) | Novel loci genome-wide significantly associated as modifiers of the age of onset of ADmore | more |
| GPR45 | GPR45:c.934C>T(p.Leu312Phe) | Expressivity | Altered onset time | P(FDR)=3.08×10(-36) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| GAL3ST4 | GAL3ST4:c.1400C>T(p.Ala467Val) | Expressivity | Altered onset time | P(FDR)=4.47×10(-2) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| GAB2 | GAB2:c.376+1387C>T | Expressivity | Altered onset time | OR=1.49, 95% CI: 1.04-2.15 | Our data independently replicate an association between GAB2 and late-onset AD, which appears to be limited to APOE epsilon4 carriers.more | more |
| FRAS1 | FRAS1:c.2450C>T(p.Ala817Val) | Expressivity | Altered onset time | P(FDR)=3.08×10(-36) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| FPR1 | FPR1:c.1037A>C(p.Glu346Ala) | Expressivity | Altered onset time | P(FDR)=1.34×10(-6) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| FAM47E | FAM47E:c.787A>C(p.Lys263Gln) | Expressivity | Altered onset time | P(FDR)=2.07×10(-3) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| EXOC2 | EXOC2:n.715196G>A | Expressivity | Altered onset time | P=3.28 × 10(-6) | Novel loci genome-wide significantly associated as modifiers of the age of onset of ADmore | more |
| EBLN1 | EBLN1:c.445G>A(p.Gly149Arg) | Expressivity | Altered onset time | P(FDR)=3.9×10(-28) | Genome-wide statistically significant mutations of major modifier effect on the the age of onset (AOO) in Azheimer's diseasemore | more |
| DAOA | DAOA:c.89G>A(p.Arg30Lys) | Expressivity | Risk factor | P=1.94×10(-4), P(FDR)=9.34×10(-3) | Polymorphisms in the DAOA gene are linked to the occurrence of neuropsychiatric symptoms such as depression, apathy, aggression, delusions, hallucinations, and psychosis in AD.more | more |